Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Pharma Mar (PHMMF) had Revenue of $189.21M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$189.21M
Net Income	$28.27M
Cost of Goods Sold	$8.85M
Gross Profit	$180.36M
Operating Expenses	$182.21M
Operating Income	$7.00M
Non-Operating Income/Expense	$5.97M
Pre-Tax Income	$12.97M
Normalized Pre-Tax Income	$12.97M
Income after Taxes	$28.27M
Income from Continuous Operations	$28.27M
Consolidated Net Income/Loss	$28.27M
Normalized Income after Taxes	$28.27M
EBIT	$7.00M
EBITDA	$14.33M
Weighted-Average Shares Outstanding (Basic)	17.54M
Weighted-Average Shares Outstanding (Diluted)	17.56M
Earnings per Share (EPS) (Basic)	$1.61
Earnings per Share (EPS) (Diluted)	$1.61
Balance Sheet Financials
Current Assets	$270.79M
Property, Plant, and Equipment	$60.50M
Long-Term Assets	$107.56M
Total Assets	$378.35M
Current Liabilities	$89.48M
Long-Term Debt	$43.14M
Long-Term Liabilities	$63.40M
Total Liabilities	$152.88M
Common Equity	$225.47M
Tangible Shareholders Equity	$224.38M
Shareholders Equity	$225.47M
Common Shares Outstanding	17.86M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$6.52M
Cash Flow from Investing Activities	$1.12M
Cash Flow from Financial Activities	$-5.79M
Beginning Cash	$64.95M
End Cash	$68.43M
Increase/Decrease in Cash	$3.48M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-12.36M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.03
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.16
Debt to Equity Ratio	0.23
Gross Margin	95.32%
Operating Margin	3.70%
EBIT Margin	3.70%
EBITDA Margin	7.57%
Pre-Tax Profit Margin	6.85%
Profit Margin	14.94%
Free Cash Flow	$-8.77M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.50
Inventory Turnover	0.16
Receiveable Turnover	5.04
Days Sales in Receivables	72.39
Return on Equity	12.54%
Return on Tangible Equity	12.60%
Return on Assets	7.47%
Return on Investments	10.52%
Book Value Per Share	$12.63
Free Cash Flow per Share	$-0.50
Operating Cash Flow per Share	$0.37

Data from Zacks Investment Research, Inc.